Skip to main content
Fig. 2 | BMC Gastroenterology

Fig. 2

From: A study on prevention of bleeding complications using lusutrombopag for safe RFA in patients with hepatocellular carcinoma with low platelet counts: prospective observational study

Fig. 2

PLT elevation according to the PLT level before lusutrombopag administration

PLT elevation according to the PLT level before lusutrombopag administration

We examined whether there was a difference in the rate of PLT elevation depending on the pre-dose PLT level. There was no difference in the rate of PLT elevation between patients who met with a pre-dose PLT level of ≥ 50,000 PLT µL− 1 and those who met with a pre-dose PLT level of < 50,000 PLT µL− 1 (p = 0.4017)

Back to article page